没有数据	没有数据

没有数据	没有数据

来源	SDS样本
Sigma-Aldrich	浏览或下载
Cayman	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Controversies over the diagnosis of oligodendroglioma: a report from the satellite workshop at the 4th international symposium of brain tumor pathology, Nagoya Congress Center, May 23, 2012.Takashi Komori et al.Brain tumor pathology, 30(4), 253-261 (2013-10-09) Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.Supriya K Saha et al.Nature, 513(7516), 110-114 (2014-07-22) IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.Rasime Kalkan et al.Gene, 554(1), 81-86 (2014-12-03) Expression of molecular markers in low-grade chondrosarcomas and cartilaginous tumors with uncertain differentiation.I V Boulytcheva et al.Klinicheskaia laboratornaia diagnostika, (10)(10), 61-63 (2014-03-20) A vaccine targeting mutant IDH1 induces antitumour immunity.Theresa Schumacher et al.Nature, 512(7514), 324-327 (2014-07-22) Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer.Wen-Liang Li et al.Gene, 546(2), 263-270 (2014-06-03) Suppression of tumorigenesis in mitochondrial NADP(+)-dependent isocitrate dehydrogenase knock-out mice.Seontae Kim et al.Biochimica et biophysica acta, 1842(2), 135-143 (2013-11-19) Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.Wolfgang Wick et al.Neurology, 81(17), 1515-1522 (2013-09-27) Direct screening of enzyme activity using infrared matrix-assisted laser desorption electrospray ionization.Milad Nazari et al.Rapid communications in mass spectrometry : RCM, 31(22), 1868-1874 (2017-08-26) Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.Liran I Shlush et al.Nature, 506(7488), 328-333 (2014-02-14) Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.Waraporn Chan-On et al.Nature genetics, 45(12), 1474-1478 (2013-11-05) Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism.He Wen et al.Journal of neurochemistry, 132(2), 183-193 (2014-09-25) Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In Vivo.Marie Pereira et al.Cell reports, 28(2), 498-511 (2019-07-11) Genetic features of oligodendrogliomas and presence of seizures. The relationship of seizures and genetics in LGOs.Linda Mulligan et al.Clinical neuropathology, 33(4), 292-298 (2014-07-06) Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.Ovidiu C Andronesi et al.The Journal of clinical investigation, 123(9), 3659-3663 (2013-09-04) Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial.Mariam G Aslanyan et al.Annals of hematology, 93(8), 1401-1412 (2014-07-06) Up-regulated isocitrate dehydrogenase 1 suppresses proliferation, migration and invasion in osteosarcoma: in vitro and in vivo.Xiang Hu et al.Cancer letters, 346(1), 114-121 (2013-12-26) IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.Hong-Bin Cheng et al.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 34(6), 3555-3559 (2013-08-02) A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).Rikke H Dahlrot et al.Journal of neuro-oncology, 114(3), 309-317 (2013-07-03) Isocitrate dehydrogenase-1 is mutated in inflammatory bowel disease-associated intestinal adenocarcinoma with low-grade tubuloglandular histology but not in sporadic intestinal adenocarcinoma.Douglas J Hartman et al.The American journal of surgical pathology, 38(8), 1147-1156 (2014-07-17) Mast cell tryptase and carboxypeptidase A expression in body fluid and gastrointestinal tract associated with drug-related fatal anaphylaxisGuo X J, et al. World Journal of Gastroenterology, 21(47), 13288-13288 (2015) Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations.Ashkan Emadi et al.Experimental hematology, 42(4), 247-251 (2013-12-18) Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.Mamiko Sakata-Yanagimoto et al.Nature genetics, 46(2), 171-175 (2014-01-15) WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.Julian Rauscher et al.Journal of clinical pathology, 67(7), 556-561 (2014-03-13) cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.Yazmin Odia et al.Journal of neuro-oncology, 115(2), 249-259 (2013-08-13) Targeting IDH: the next big thing in AML.Mark Levis Blood, 122(16), 2770-2771 (2013-10-19) Glioma biology and molecular markers.Adam L Cohen et al.Cancer treatment and research, 163, 15-30 (2014-12-04) The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation.Remco J Molenaar et al.Biochimica et biophysica acta, 1846(2), 326-341 (2014-06-01) Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.Guido Reifenberger et al.International journal of cancer, 135(8), 1822-1831 (2014-03-13) Isocitrate dehydrogenase mutations in leukemia.Anna Sophia McKenney et al.The Journal of clinical investigation, 123(9), 3672-3677 (2013-09-04) NADP(+)-specific isocitrate dehydrogenase from oleaginous yeast Yarrowia lipolytica CLIB122: biochemical characterization and coenzyme sites evaluation.Xue Li et al.Applied biochemistry and biotechnology, 171(2), 403-416 (2013-07-13) Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China.Chuan-Bao Zhang et al.Journal of cancer research and clinical oncology, 140(1), 45-51 (2013-10-24) Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China.Jiang-Han Wang et al.Proceedings of the National Academy of Sciences of the United States of America, 110(42), 17017-17022 (2013-10-02) Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.Anuhar Chaturvedi et al.Blood, 122(16), 2877-2887 (2013-08-21) Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.Maxime Janin et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(4), 297-305 (2013-12-18) Glioblastoma in the elderly.Marc C Chamberlain Cancer treatment and research, 163, 159-170 (2014-12-04) Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro.S M Sarkaria et al.Leukemia, 28(12), 2403-2406 (2014-08-06) IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma.Chunzhi Zhang et al.Neuro-oncology, 15(9), 1114-1126 (2013-07-24) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomasSanson M, et al. Journal of Clinical Oncology, 27(25), 4150-4154 (2009) Metabolic quirks yield tumour hope.Heidi Ledford Nature, 508(7495), 158-159 (2014-04-11) Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study.Paola Guglielmelli et al.Blood, 123(14), 2157-2160 (2014-01-25) Elevated plasma 2-hydroxyglutarate in acute myeloid leukaemia: association with the IDH1 SNP rs11554137 and severe renal impairment.Daniel H Wiseman et al.British journal of haematology, 166(1), 145-148 (2014-03-13) Recent aspects of classification and epidemiology of epilepsy-associated tumors.Anna Japp et al.Epilepsia, 54 Suppl 9, 5-11 (2013-12-18) The evolving landscape in the therapy of acute myeloid leukemia.Grace L Peloquin et al.Protein & cell, 4(10), 735-746 (2013-08-29) IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.Chien-Chin Lin et al.American journal of hematology, 89(2), 137-144 (2013-10-12) [The role of the pathologist in the diagnosis and therapy planning of central nervous system tumors. Prognostic and predictive markers].Eszter Turányi et al.Magyar onkologia, 57(4), 215-221 (2013-12-20) Low-grade glioma.Priya Kumthekar et al.Cancer treatment and research, 163, 75-87 (2014-12-04)

备注